Bristol-Myers Squibb
BMY
BMY
1,518 hedge funds and large institutions have $63.3B invested in Bristol-Myers Squibb in 2016 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 663 increasing their positions, 547 reducing their positions, and 147 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,518
Holders Change
-55
Holders Change %
-3.5%
% of All Funds
40.57%
Holding in Top 10
49
Holding in Top 10 Change
-61
Holding in Top 10 Change %
-55.45%
% of All Funds
1.31%
New
109
Increased
663
Reduced
547
Closed
147
Calls
$1.15B
Puts
$1.38B
Net Calls
-$227M
Net Calls Change
-$366M
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$2.43B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$2.52B |
| 3 |
Jennison Associates
New York
|
$985M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
$18.4M |
| 5 |
Wells Fargo
San Francisco,
California
|
$426M |
